8Y3V image
Entry Detail
PDB ID:
8Y3V
EMDB ID:
Keywords:
Title:
The self-assembled nanotube of CPC46A/Q70V
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2024-01-29
Release Date:
2024-11-06
Method Details:
Experimental Method:
Resolution:
3.46 Å
Aggregation State:
HELICAL ARRAY
Reconstruction Method:
HELICAL
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Capsid protein
Mutations:C47A, Q71V
Chain IDs:A, B, C, D
Chain Length:129
Number of Molecules:4
Biological Source:Emesvirus zinderi
Ligand Molecules
Primary Citation
Transformation of a Viral Capsid from Nanocages to Nanotubes and Then to Hydrogels: Redirected Self-Assembly and Effects on Immunogenicity.
Acs Nano 18 13755 13767 (2024)
PMID: 38752610 DOI: 10.1021/acsnano.4c01969

Abstact

The ability to manipulate the self-assembly of proteins is essential to understanding the mechanisms of life and beneficial to fabricating advanced nanomaterials. Here, we report the transformation of the MS2 phage capsid from nanocages to nanotubes and then to nanotube hydrogels through simple point mutations guided by interfacial interaction redesign. We demonstrate that site 70, which lies in the flexible FG loop of the capsid protein (CP), is a "magic" site that can largely dictate the final morphology of assemblies. By varying the amino acid at site 70, with the aid of a cysteine-to-alanine mutation at site 46, we achieved the assembly of double-helical or single-helical nanotubes in addition to nanocages. Furthermore, an additional cysteine substitution on the surface of nanotubes mediated their cross-linking to form hydrogels with reducing agent responsiveness. The hierarchical self-assembly system allowed for the investigation of morphology-related immunogenicity of MS2 CPs, which revealed dramatic differences among nanocages, nanotubes, and nanotube hydrogels in terms of immune response types, antibody levels and T cell functions. This study provides insights into the assembly manipulation of protein nanomaterials and the customized design of nanovaccines and drug delivery systems.

Legend

Protein

Chemical

Disease

Primary Citation of related structures